Publikationen in Zusammenarbeit mit Forschern von Aarhus University Hospital (73)

2024

  1. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259

  2. Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes

    Cardiovascular Revascularization Medicine, Vol. 64, pp. 7-14

  3. Impact of gender in patients with device-related thrombosis after left atrial appendage closure – A sub-analysis from the multicenter EUROC-DRT-registry

    Echocardiography, Vol. 41, Núm. 8

  4. Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 1, pp. 85-94

  5. Position Statement on Cardiac Computed Tomography Following Left Atrial Appendage Occlusion

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 15, pp. 1747-1764

  6. Predictors of anastomotic leak and conduit necrosis after oesophagectomy: Results from the oesophago-gastric anastomosis audit (OGAA)

    European Journal of Surgical Oncology, Vol. 50, Núm. 6

  7. Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity

    European Journal of Heart Failure

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post-market surveillance study

    EuroIntervention, Vol. 19, Núm. 1, pp. 83-92

  3. Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

    Blood, Vol. 141, Núm. 2, pp. 156-167

  4. Impact of Device Implant Depth After Left Atrial Appendage Occlusion

    JACC. Cardiovascular interventions, Vol. 16, Núm. 17, pp. 2139-2149

  5. Latest-iteration balloon- and self-expandable transcatheter valves for severe bicuspid aortic stenosis: the TRITON study

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 872-880

  6. Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacement

    Frontiers in Cardiovascular Medicine, Vol. 10

  7. Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry

    Clinical Research in Cardiology, Vol. 112, Núm. 12, pp. 1790-1799

2022

  1. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry

    Clinical Research in Cardiology, Vol. 111, Núm. 11, pp. 1276-1285

  2. Correction to: Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19 (Intensive Care Medicine, (2022), 48, 4, (435-447), 10.1007/s00134-022-06642-z)

    Intensive Care Medicine

  3. Health-related quality of life in older patients surviving ICU treatment for COVID-19: results from an international observational study of patients older than 70 years

    Age and Ageing, Vol. 51, Núm. 2

  4. Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19

    Intensive Care Medicine, Vol. 48, Núm. 4, pp. 435-447

  5. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    Blood, Vol. 140, Núm. 11, pp. 1229-1253

  6. The association of the Activities of Daily Living and the outcome of old intensive care patients suffering from COVID-19

    Annals of Intensive Care, Vol. 12, Núm. 1